KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cvs Health (CVS) Cost of Revenue (2016 - 2025)

Cvs Health (CVS) has disclosed Cost of Revenue for 17 consecutive years, with -$47.5 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cost of Revenue fell 127.12% year-over-year to -$47.5 billion, compared with a TTM value of $45.0 billion through Dec 2025, down 80.07%, and an annual FY2025 reading of $45.0 billion, down 78.2% over the prior year.
  • Cost of Revenue was -$47.5 billion for Q4 2025 at Cvs Health, down from $32.0 billion in the prior quarter.
  • Across five years, Cost of Revenue topped out at $175.1 billion in Q4 2024 and bottomed at -$92.4 billion in Q4 2021.
  • Average Cost of Revenue over 5 years is $22.8 billion, with a median of $16.8 billion recorded in 2021.
  • The sharpest move saw Cost of Revenue tumbled 710.13% in 2021, then soared 788.92% in 2025.
  • Year by year, Cost of Revenue stood at -$92.4 billion in 2021, then soared by 84.02% to -$14.8 billion in 2022, then surged by 485.52% to $56.9 billion in 2023, then surged by 207.64% to $175.1 billion in 2024, then tumbled by 127.12% to -$47.5 billion in 2025.
  • Business Quant data shows Cost of Revenue for CVS at -$47.5 billion in Q4 2025, $32.0 billion in Q3 2025, and $49.4 billion in Q2 2025.